General survival analysis among different subtypes showed that the average patient survival in Luminal A and Basal group was longer than in Luminal B and Her2 group, indicating the latter two were the relatively poorer-prognostic subtypes in breast cancer (Figure 1B, Table 1, Supplementary Data Set Table 1). This evidence concerns the gene ERBB2 and breast carcinoma.